SABIO HOLDINGS INC (SBIO.CA) Stock Fundamental Analysis
TSX-V:SBIO - TSX Venture Exchange - CA78570Q1081 - Common Stock - Currency: CAD
We assign a fundamental rating of 5 out of 10 to SBIO. SBIO was compared to 11 industry peers in the Media industry. Both the profitability and the financial health of SBIO get a neutral evaluation. Nothing too spectacular is happening here. SBIO is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
SBIO had positive earnings in the past year.
In the past year SBIO had a positive cash flow from operations.
In the past 5 years SBIO always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: SBIO reported negative operating cash flow in multiple years.
1.2 Ratios
SBIO's Return On Assets of -0.48% is amongst the best of the industry. SBIO outperforms 90.91% of its industry peers.
SBIO has a Return On Invested Capital of 212.13%. This is amongst the best in the industry. SBIO outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.48% | ||
| ROE | N/A | ||
| ROIC | 212.13% |
ROA(3y)-9.32%
ROA(5y)-8.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Operating Margin value of 4.35%, SBIO is doing good in the industry, outperforming 72.73% of the companies in the same industry.
In the last couple of years the Operating Margin of SBIO has grown nicely.
With an excellent Gross Margin value of 61.75%, SBIO belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
In the last couple of years the Gross Margin of SBIO has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.35% | ||
| PM (TTM) | N/A | ||
| GM | 61.75% |
OM growth 3Y45.05%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SBIO is creating value.
Compared to 1 year ago, SBIO has more shares outstanding
The debt/assets ratio for SBIO has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.84 indicates that SBIO is not a great score, but indicates only limited risk for bankruptcy at the moment.
SBIO's Altman-Z score of 1.84 is amongst the best of the industry. SBIO outperforms 100.00% of its industry peers.
The Debt to FCF ratio of SBIO is 2.33, which is a good value as it means it would take SBIO, 2.33 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of SBIO (2.33) is better than 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.33 | ||
| Altman-Z | 1.84 |
ROIC/WACC28.67
WACC7.4%
2.3 Liquidity
A Current Ratio of 0.83 indicates that SBIO may have some problems paying its short term obligations.
SBIO has a Current ratio (0.83) which is comparable to the rest of the industry.
SBIO has a Quick Ratio of 0.83. This is a bad value and indicates that SBIO is not financially healthy enough and could expect problems in meeting its short term obligations.
SBIO has a Quick ratio (0.83) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.83 |
3. Growth
3.1 Past
SBIO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 97.32%, which is quite impressive.
SBIO shows a strong growth in Revenue. In the last year, the Revenue has grown by 37.96%.
The Revenue has been growing by 26.99% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)97.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.22%
Revenue 1Y (TTM)37.96%
Revenue growth 3Y26.99%
Revenue growth 5YN/A
Sales Q2Q%44.43%
3.2 Future
SBIO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 135.69% yearly.
SBIO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.46% yearly.
EPS Next Y203%
EPS Next 2Y135.69%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.25%
Revenue Next 2Y11.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 52.00 indicates a quite expensive valuation of SBIO.
90.91% of the companies in the same industry are more expensive than SBIO, based on the Price/Earnings ratio.
SBIO is valuated expensively when we compare the Price/Earnings ratio to 24.21, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 12.35 indicates a correct valuation of SBIO.
90.91% of the companies in the same industry are more expensive than SBIO, based on the Price/Forward Earnings ratio.
SBIO's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 52 | ||
| Fwd PE | 12.35 |
4.2 Price Multiples
SBIO's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, SBIO is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.11 | ||
| EV/EBITDA | 7.66 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SBIO's earnings are expected to grow with 135.69% in the coming years.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y135.69%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for SBIO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:SBIO (5/9/2025, 7:00:00 PM)
0.52
+0.02 (+4%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners48.7%
Ins Owner ChangeN/A
Market Cap26.05M
Analysts85.71
Price Target1.36 (161.54%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.14%
Min EPS beat(2)-25.74%
Max EPS beat(2)32.01%
EPS beat(4)3
Avg EPS beat(4)2.06%
Min EPS beat(4)-25.74%
Max EPS beat(4)32.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.75%
Min Revenue beat(2)4.43%
Max Revenue beat(2)11.08%
Revenue beat(4)3
Avg Revenue beat(4)4.18%
Min Revenue beat(4)-1.44%
Max Revenue beat(4)11.08%
Revenue beat(8)5
Avg Revenue beat(8)-2.07%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.66%
PT rev (3m)-3.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-8.54%
Revenue NQ rev (3m)-28.46%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)0.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 52 | ||
| Fwd PE | 12.35 | ||
| P/S | 0.38 | ||
| P/FCF | 5.11 | ||
| P/OCF | 4.97 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.66 |
EPS(TTM)0.01
EY1.92%
EPS(NY)0.04
Fwd EY8.09%
FCF(TTM)0.1
FCFY19.58%
OCF(TTM)0.1
OCFY20.12%
SpS1.38
BVpS-0.03
TBVpS-0.1
PEG (NY)0.26
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.48% | ||
| ROE | N/A | ||
| ROCE | 294.62% | ||
| ROIC | 212.13% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 4.35% | ||
| PM (TTM) | N/A | ||
| GM | 61.75% | ||
| FCFM | 7.4% |
ROA(3y)-9.32%
ROA(5y)-8.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y45.05%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5YN/A
F-Score8
Asset Turnover2.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.33 | ||
| Debt/EBITDA | 0.56 | ||
| Cap/Depr | 11.65% | ||
| Cap/Sales | 0.21% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 124.05% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.83 | ||
| Altman-Z | 1.84 |
F-Score8
WACC7.4%
ROIC/WACC28.67
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.22%
EPS Next Y203%
EPS Next 2Y135.69%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)37.96%
Revenue growth 3Y26.99%
Revenue growth 5YN/A
Sales Q2Q%44.43%
Revenue Next Year6.25%
Revenue Next 2Y11.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y157.97%
EBIT growth 3Y84.2%
EBIT growth 5YN/A
EBIT Next Year88.07%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y173.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y175.88%
OCF growth 3YN/A
OCF growth 5YN/A